550 related articles for article (PubMed ID: 20652847)
21. Neoplastic skin lesions in Iranian renal transplant recipients: the role of immunosuppressive therapy.
Zamanian A; Farshchian M
J Drugs Dermatol; 2007 Jul; 6(7):703-6. PubMed ID: 17763593
[TBL] [Abstract][Full Text] [Related]
22. Non-melanoma skin cancer risk in the Queensland renal transplant population.
Ramsay HM; Fryer AA; Hawley CM; Smith AG; Harden PN
Br J Dermatol; 2002 Nov; 147(5):950-6. PubMed ID: 12410706
[TBL] [Abstract][Full Text] [Related]
23. Skin Cancers in Medicare Beneficiaries With Actinic Keratoses.
Mohr C; Li Y; Navsaria LJ; Hinkston CL; Shete SS; Margolis DJ; Wehner MR
JAMA Dermatol; 2023 Dec; 159(12):1368-1372. PubMed ID: 37938822
[TBL] [Abstract][Full Text] [Related]
24. Subsequent squamous- and basal-cell carcinomas in kidney-transplant recipients after the first skin cancer: cumulative incidence and risk factors.
Wisgerhof HC; Edelbroek JR; de Fijter JW; Haasnoot GW; Claas FH; Willemze R; Bavinck JN
Transplantation; 2010 May; 89(10):1231-8. PubMed ID: 20410852
[TBL] [Abstract][Full Text] [Related]
25. Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma.
Schmitz L; Gambichler T; Gupta G; Stücker M; Dirschka T
J Eur Acad Dermatol Venereol; 2018 May; 32(5):752-756. PubMed ID: 29117441
[TBL] [Abstract][Full Text] [Related]
26. Distinct immunohistochemical phenotype of nonmelanoma skin cancers between renal transplant and immunocompetent populations.
Gutiérrez-Dalmau A; Revuelta I; Ferrer B; Mascaró JM; Oppenheimer F; Albanell J; Campistol JM
Transplantation; 2010 Nov; 90(9):986-92. PubMed ID: 20844469
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology and clinical evolution of non-melanoma skin cancer in renal transplant recipients: a single-center experience in São Paulo, Brazil.
Hayashida MZ; Fernandes VM; Fernandes DR; Ogawa MM; Tomimori J
Int J Dermatol; 2015 Oct; 54(10):e383-8. PubMed ID: 25969871
[TBL] [Abstract][Full Text] [Related]
28. [Risk factors of non melanoma skin cancers in kidney transplant patients].
Sułowicz J; Wojas-Pelc A; Ignacak E; Betkowska-Prokop A; Kuzniewski M; Sułowicz W
Przegl Lek; 2014; 71(1):19-25. PubMed ID: 24712264
[TBL] [Abstract][Full Text] [Related]
29. Actinic Keratosis Diagnosis and Increased Risk of Developing Skin Cancer: A 10-year Cohort Study of 17,651 Patients in Sweden.
Guorgis G; Anderson CD; Lyth J; Falk M
Acta Derm Venereol; 2020 Apr; 100(8):adv00128. PubMed ID: 32314794
[TBL] [Abstract][Full Text] [Related]
30. Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention Trial.
Criscione VD; Weinstock MA; Naylor MF; Luque C; Eide MJ; Bingham SF;
Cancer; 2009 Jun; 115(11):2523-30. PubMed ID: 19382202
[TBL] [Abstract][Full Text] [Related]
31. Accrual of non-melanoma skin cancer in renal-transplant recipients: experience of a Victorian tertiary referral institution.
Ng JC; Cumming S; Leung V; Chong AH
Australas J Dermatol; 2014 Feb; 55(1):43-8. PubMed ID: 23808627
[TBL] [Abstract][Full Text] [Related]
32. Comparison of skin cancers in liver and renal transplant recipients: Results of a prospective study in an Australian tertiary referral centre.
Ge L; Chee SN; Robledo KP; Lowe P
Australas J Dermatol; 2018 Nov; 59(4):291-296. PubMed ID: 29292515
[TBL] [Abstract][Full Text] [Related]
33. First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients.
Mackenzie KA; Wells JE; Lynn KL; Simcock JW; Robinson BA; Roake JA; Currie MJ
Nephrol Dial Transplant; 2010 Jan; 25(1):300-6. PubMed ID: 19783601
[TBL] [Abstract][Full Text] [Related]
34. Risk of skin cancer development in 672 patients affected by actinic keratosis.
Dika E; Fanti PA; Misciali C; Vaccari S; Crisman G; Barisani A; Baraldi C; Ribero S; Patrizi A
G Ital Dermatol Venereol; 2016 Dec; 151(6):628-633. PubMed ID: 26381460
[TBL] [Abstract][Full Text] [Related]
35. Risk of Non-melanoma Skin Cancer in Patients with Atopic Dermatitis Treated with Oral Immunosuppressive Drugs.
Garritsen FM; van der Schaft J; van den Reek JM; Politiek K; van Os-Medendorp H; van Dijk M; Hijnen DJ; de Graaf M; Bruijnzeel-Koomen CA; de Jong EM; Schuttelaar MA; Bruin-Weller MS
Acta Derm Venereol; 2017 Jun; 97(6):724-730. PubMed ID: 28218345
[TBL] [Abstract][Full Text] [Related]
36. Nonmelanoma Skin Cancer Frequency and Risk Factors in Australian Heart and Lung Transplant Recipients.
De Rosa N; Paddon VL; Liu Z; Glanville AR; Parsi K
JAMA Dermatol; 2019 Jun; 155(6):716-719. PubMed ID: 30865218
[TBL] [Abstract][Full Text] [Related]
37. Metal arc welding and the risk of skin cancer.
Heltoft KN; Slagor RM; Agner T; Bonde JP
Int Arch Occup Environ Health; 2017 Nov; 90(8):873-881. PubMed ID: 28766013
[TBL] [Abstract][Full Text] [Related]
38. Skin Cancer Development in Solid Organ Transplant Recipients in Switzerland (Swiss Transplant Cohort Study).
Stenz NA; Stampf S; Arnold AW; Cozzio A; Dickenmann M; Gaide O; Harms M; Hunger RE; Laffitte E; Mühlstädt M; Nägeli M; Hofbauer GFL;
Dermatology; 2021; 237(6):970-980. PubMed ID: 33227788
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic Delays for Non-melanoma Skin Cancers in Renal Transplant Recipients during the COVID-19 Pandemic: What is Hiding Behind the Mask?
Mokos M; Bašić-Jukić N
Acta Dermatovenerol Croat; 2021 Jul; 29(2):111-113. PubMed ID: 34477079
[TBL] [Abstract][Full Text] [Related]
40. Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Neuberger A; Menzer C; Volk N; Enk AH; Hadaschik EN; Lonsdorf AS
Eur J Dermatol; 2021 Oct; 31(5):609-615. PubMed ID: 34903507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
